U.S. Markets open in 6 hrs 9 mins

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today

·2 min read
Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

A report from Bloomberg News today said that the biopharma heavyweight Bristol Myers Squibb (NYSE: BMY) might be interested in buying Aurinia Pharmaceuticals for an undisclosed sum. The report also noted that Bristol could still walk away from the negotiations. Rumors of a buyout of Aurinia are nothing new.